Home    Back

299. Cystic fibrosis
1,592 clinical trials,   1,539 drugs   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2015-002677-38-BE
(EUCTR)		11/05/201603/03/2016An investigation of the effect of CTX-4430 on lung inflammation in patients with cystic fibrosisA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients with Cystic Fibrosis - EMPIRE CF Cystic Fibrosis
MedDRA version: 20.0;Level: PT;Classification code 10011763;Term: Cystic fibrosis lung;System Organ Class: 10010331 - Congenital, familial and genetic disorders
MedDRA version: 20.0;Classification code 10011762;Term: Cystic fibrosis;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]		Product Name: CTX-4430
Product Code: CTX-4430
INN or Proposed INN: acebilustat
Other descriptive name: CRC3357, ZK-355322, Leukoton
Product Name: CTX-4430
Product Code: CTX-4430
INN or Proposed INN: acebilustat
Other descriptive name: CRC3357, ZK-355322, Leukoton		Celtaxsys Inc.NULLNot RecruitingFemale: yes
Male: yes		195Phase 2France;United States;Canada;Belgium;Germany;Italy;United Kingdom
2EUCTR2015-002677-38-DE
(EUCTR)		09/05/201603/11/2015An investigation of the effect of CTX-4430 on lung inflammation in patients with cystic fibrosisA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients with Cystic Fibrosis - EMPIRE CF Cystic Fibrosis
MedDRA version: 20.0;Level: PT;Classification code 10011763;Term: Cystic fibrosis lung;System Organ Class: 10010331 - Congenital, familial and genetic disorders
MedDRA version: 20.0;Classification code 10011762;Term: Cystic fibrosis;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]		Product Name: CTX-4430
Product Code: CTX-4430
INN or Proposed INN: acebilustat
Other descriptive name: CRC3357, ZK-355322, Leukoton
Product Name: CTX-4430
Product Code: CTX-4430
INN or Proposed INN: acebilustat
Other descriptive name: CRC3357, ZK-355322, Leukoton		Celtaxsys Inc.NULLNot RecruitingFemale: yes
Male: yes		195Phase 2France;United States;Canada;Belgium;Germany;Italy;United Kingdom
3EUCTR2015-002677-38-IT
(EUCTR)		06/04/201625/11/2015An investigation of the effect of CTX-4430 on lung inflammation in patients with cystic fibrosisA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients with Cystic Fibrosis - EMPIRE CF Cystic Fibrosis
MedDRA version: 18.1;Level: PT;Classification code 10011763;Term: Cystic fibrosis lung;System Organ Class: 10010331 - Congenital, familial and genetic disorders
MedDRA version: 18.1;Classification code 10011762;Term: Cystic fibrosis;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]		Product Name: CTX-4430
Product Code: CTX-4430
INN or Proposed INN: acebilustat
Other descriptive name: CRC3357, ZK-355322, Leukoton
Product Name: CTX-4430
Product Code: CTX-4430
INN or Proposed INN: acebilustat
Other descriptive name: CRC3357, ZK-355322, Leukoton		Celtaxsys Inc.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		195Phase 2France;United States;Belgium;Netherlands;Germany;United Kingdom;Italy